Ajmaline blocks I(Na) and I(Kr) without eliciting differences between Brugada syndrome patient and control human pluripotent stem cell-derived cardiac clusters

The class Ia anti-arrhythmic drug ajmaline is used clinically to unmask latent type I ECG in Brugada syndrome (BrS) patients, although its mode of action is poorly characterised. Our aims were to identify ajmaline's mode of action in human induced pluripotent stem cell (hiPSC)-derived cardiomyo...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Duncan C., Harmer, Stephen C., Poliandri, Ariel, Nobles, Muriel, Edwards, Elizabeth C., Ware, James S., Sharp, Tyson V., McKay, Tristan R., Dunkel, Leo, Lambiase, Pier D., Tinker, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727153/
https://www.ncbi.nlm.nih.gov/pubmed/29172153
http://dx.doi.org/10.1016/j.scr.2017.11.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727153/
https://www.ncbi.nlm.nih.gov/pubmed/29172153
http://dx.doi.org/10.1016/j.scr.2017.11.003

Ejemplares similares